Our International Scientific Advisory Board is comprised of
some of the world's foremost experts in
fields ranging from Immunology to
Anti-Aging. The purpose of this team is to
advise BioBancUSA on operational activities
such as the prediction and maintenance of
industry standards, research programs,
advanced therapeutics, white blood cell
applications, and cryogenics. This level of
professional expertise provides BioBancUSA
the continued support to meet the needs of
our members today and into tomorrow.
|
Dominique Charron, MD, Ph D
Chair of the Scientific
Advisory Board
Dr. Charron is Professor of
Immunology, Head of
Transplantation Biology and Translational
Research at the
Hospital Saint Louis
in Paris, a leading hospital associated with
the Nobel Prize for discovery of HLA system
in 1980, and the first cord blood
transplantation in 1988. His research
interests include Immunogenetics,
transplantation biology and medicine. He
has received many
international honors include
the Grand Prix Claude
Bernard for Medical Research
and the Ceppellini Lecture
award and has served as
chairman of the International
Histocompatibility Workshop and Conference.
Dr. Charron has also been published
in over 400
scientific papers in basic
translational medical science.
For further information and his
distinguished accomplishments, please see
Dr. Charron's |
 |
|
Professional
Biography |
Pr. Dominique Charron
and his team from The Hospital
Saint Louis, Paris, France |
|
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - |
|
Michel Sadelain, MD, PhD
Located at the Memorial
Sloan-Kettering Institute,
Dr. Sadelain is Director of
the Gene Transfer and
Somatic Cell Engineering
Facility and a Stephen and
Barbara Friedman Chair. He
received his MD at The
University of Paris and a
PhD at The University of
Alberta, followed by a
residency at Centre
Hospitalier Universitaire
Saint-Antoine (Paris) and a
fellowship at Massachusetts
Institute of Technology.
With his clinical expertise
in Gene Transfer and Genetic
Therapies; Congenital and
Acquired Disorders of the
Hematopoietic and Immune
Systems; Immunotherapy, Dr.
Sadelain and his team are
actively conducting research
at the Gene Transfer and
Somatic Cell Engineering
Facility, and
investigating how to control
transgene expression in
vivo in hematopoietic
stem cells and how to
augment immune responses
against tumor cells.
Dr. Sadelain is also
conducting research at The
Gene Transfer and Somatic
Cell Engineering Facility.
The facility is responsible
for the production of
clinical grade retroviral
vectors and plasmid DNA for
gene therapy clinical
trials. The transduction
facility focuses on the
genetic engineering of
hematopoietic stem cells,
dendritic cells, and T
lymphocytes.
His team is also using gene transfer technology in order to
investigate the molecular
pathways that influence the
differentiation of naïve T
lymphocytes toward the Th1
or Th2 phenotype. This may
play a crucial role in the
outcome of immune responses
against foreign or self
antigens, including those
expressed in tumor cells.
Dr. Salelain’s work has been
published in numerous
publications and may be
viewed at Pub Med
click here
|
 |
|
Michel
Sadelain, MD, Ph D |
|
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - |
Marc Weksler, MD
Dr. Weksler is a renowned
aging specialist and a
Wright Professor of Medicine
at Weill Medical College of
Cornell University in New
York. He received his BA in
Zoology from
Swarthmore College and his
MD from the College of
Physicians and Surgeons at
Columbia University. His
research and professional
experience spans four
decades and he has received
numerous awards.
An aging specialist, Dr.
Weksler is widely known as
both an international
speaker and an active
participate in public
service. Over the past 20
years, Dr. Weksler has been
involved with the NIH, Aging
Review Committee,
NIA-NIAID Taskforce on
Immunology and Aging and the
Gerontology Consultant,
Fonds National de la
Recherche, Luxembourg.
Dr. Weksler has been
published in numerous
periodicals including the
book Stress, Immunity and
Aging
click here
For a list of published
articles and a complete
professional profile on Dr.
Weksler, click here. |
 |
|
Professional
Biography |
Dr.
Marc Weksler |
|
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - |
Janko Nikolich-Zugich, MD, Ph D
A Senior Scientist at the Oregon
National Primate Research Center, Dr.
Nikolich-Zugich practices at the
Vaccine and Gene Therapy
Institute and holds joint
appointments as a Professor in
the Department of Molecular
Microbiology and Immunology. He
is a member of the NIH Cellular
and Molecular Immunology-B Study
Section and of multiple NIA and
NIAID review panels.
Dr. Nikolich-Zurgich is a
graduate of the Belgrade
University Medical School, where
he received his MD, MSc and Ph D
in Immunology. His many
accomplishments include being a
Research Associate at the
Scripps Research Foundation,
Head of both the Flow Cytometry
Core Facility and the Laboratory
of T Cell Development at
Memorial Sloan-Kettering. In
addition, he has served as an
Assistant Professor and an
Associate Professor at both the
Cornell University Graduate
School of Medical Sciences and
the Division of Molecular
Medicine in Cornell University
School of Medicine and has been
honored with several
distinguished awards. |
|
|
|
